UNVERIFIEDSingle Source
STAT+: The extremism of the FDA’s Marks and Prasad has come with costs
Stat News|3/5/2026
B
Biotech
157 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
79
Activity (Last 30 Days)
2
6
6
4
3
3
6
2
4
4
4
1
5
3
3
5
2
4
1
2
2026-02-042026-03-05
Top Publishers
Stat News76 stories
Google News2 stories
Nature1 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: FDA warns more telehealth firms about compounded GLP-1s
Stat News|3/4/2026
BREAKINGMulti-Source
STAT+: Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: Prime Medicine to seek approval for gene editing treatment after two-patient trial
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: FDA is ‘not convinced’ UniQure’s Huntington’s therapy has benefit, senior official says
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: UniQure plans to seek approval for Huntington’s therapy still blocked by FDA
Stat News|3/2/2026
UNVERIFIEDSingle Source
STAT+: Sarepta Therapeutics CEO Doug Ingram will retire after a tumultuous decade
Stat News|2/26/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk strikes deal with U.S. startup to develop oral obesity, diabetes drugs
Stat News|2/25/2026
UNVERIFIEDSingle Source
STAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experiments
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: New treatment approach could give IBD patients hope, and be a bonanza for drugmakers
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: Novo’s next-gen obesity drug stumbles in Lilly comparison study
Stat News|2/23/2026
UNVERIFIEDSingle Source
STAT+: Gossamer lung disease drug fails late-stage study, but company will still seek FDA approval
Stat News|2/23/2026
UNVERIFIEDSingle Source
STAT+: Key study of Grail’s cancer detection test fails in setback for company
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: In first speech to her FDA staff, Høeg says she’ll scrutinize RSV shots and SSRIs in pregnancy
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: What to expect from Gossamer Bio’s late-stage lung disease study
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: The FDA’s Moderna pirouette is one more sign of chaos at the agency
Stat News|2/18/2026
UNVERIFIEDSingle Source
STAT+: Biotech startup raises $175 million to advance Alzheimer’s antibody therapy
Stat News|2/18/2026
UNVERIFIEDSingle Source
STAT+: FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher
Stat News|2/13/2026
UNVERIFIEDSingle Source
STAT+: Moderna’s president weighs in on FDA’s decision not to review its flu vaccine
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: FDA’s rejection of Moderna threatens to stifle broader vaccine industry
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: BridgeBio drug for genetic cause of dwarfism succeeds in key study
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: The old Vinay Prasad never left. He just changed jobs
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: Biotech doubles financing in quest to silence genes behind neurological diseases
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: ‘Moonshot’ agency ARPA-H lays off staff meant to commercialize breakthroughs
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: White House looks for more drug pricing deals to add to TrumpRx
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: Roivant immune drug significantly outperformed placebo in treating rare skin disease
Stat News|2/6/2026
UNVERIFIEDSingle Source
What to know about TrumpRx, the Trump administration’s prescription drug platform
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Vertex’s CRISPR treatment for sickle cell disease hits unexpected roadblock
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment
Stat News|2/4/2026
UNVERIFIEDSingle Source
STAT+: FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: FDA’s new ‘plausible mechanism pathway’ for personalized gene editing raises concerns
Stat News|1/26/2026